![Felix Theeuwes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Felix Theeuwes
No open positions remaining
Profile
Felix Theeuwes is the founder of DURECT Corp., which was founded in 1998.
He held the title of Chairman in 2018.
Dr. Theeuwes also held former positions as a Director at Genetronics Biomedical Corp.
and Inovio Pharmaceuticals, Inc. He was the President-New Ventures at ALZA Corp.
from 1982 to 1998.
Dr. Theeuwes received his undergraduate and graduate degrees from Katholieke Universiteit Leuven.
He also received a doctorate from Katholieke Universiteit Leuven in 1966.
Former positions of Felix Theeuwes
| Companies | Position | End |
|---|---|---|
| DURECT | Founder | 2018-12-30 |
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 2007-05-03 |
Genetronics Biomedical Corp.
 Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Director/Board Member | 2005-04-04 |
| ALZA CORPORATION | Corporate Officer/Principal | 1998-07-31 |
Training of Felix Theeuwes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Commercial Services |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Felix Theeuwes
